SEC Filings

Filing date	Form	Description	View
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-001997.pdf 0001179110-17-001997.rtf 0001179110-17-001997.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002001.pdf 0001179110-17-002001.rtf 0001179110-17-002001.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002000.pdf 0001179110-17-002000.rtf 0001179110-17-002000.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002002.pdf 0001179110-17-002002.rtf 0001179110-17-002002.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002003.pdf 0001179110-17-002003.rtf 0001179110-17-002003.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002004.pdf 0001179110-17-002004.rtf 0001179110-17-002004.xls
02/03/17	SC 13D/A	An amendment to a SC 13D filing	View HTML 0000903423-17-000038.pdf 0000903423-17-000038.rtf 0000903423-17-000038.xls
01/27/17	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000215457-17-001769.pdf 0000215457-17-001769.rtf
01/09/17	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-17-001316.pdf 0001104659-17-001316.rtf 0001104659-17-001316.xls
12/23/16	CT ORDER	CT ORDER	View HTML 9999999997-16-028005.pdf

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools